Ingrid og Jørgen har vært på vift til nordisk infeksjonskonferanse i København - gled deg til en potpurri av info om endokardittbehandling, staph aureus-bakteriemi, fecal mikrobiotatransplantasjon og veldig mye annet!
Ordforklaring:
FMT = fekal mikrobiotatransplantasjon. S.aureus = gule stafylokker (bakterie). Bakteriemi = bakterier i blodbanen. Sputum/ekspektorat = slim fra nedre luftveier. Nasofarynx = området mellom svelg og nese (øvre luftveier) der mange luftveisprøver tas fra. PCR = polymerase chain reaction, analysemetode.
Referanser:
1. Kibsgaard HL, Mathisen M, Kofstad T, Heggelund L, Muller KE. Microbiological sampling in lower respiratory tract infections: comparing nasopharyngeal and sputum specimens. Infect Dis (Lond). 2026:1-11.
2. Bundgaard H, Pries-Heje M, Hjulmand J, Hasselbalch R, Jorgensen PG, Fano S, et al. Response-Tailored or Standard-Duration Antibiotic Treatment for Infective Endocarditis. N Engl J Med. 2026.
3. Bier N, Hanson B, Jiang ZD, DuPont HL, Arias CA, Miller WR. A Case of Successful Treatment of Recurrent Urinary Tract Infection by Extended-Spectrum beta-Lactamase Producing Klebsiella pneumoniae Using Oral Lyophilized Fecal Microbiota Transplant. Microb Drug Resist. 2023;29(1):34-8.
4. Lemiengre MB, van Driel ML, Merenstein D, Liira H, Makela M, De Sutter AI. Antibiotics for acute rhinosinusitis in adults. Cochrane Database Syst Rev. 2018;9(9):CD006089.
5. Venekamp RP, Sanders SL, Glasziou PP, Rovers MM. Antibiotics for acute otitis media in children. Cochrane Database Syst Rev. 2023;11(11):CD000219.
6. Lemaignen A, Bernard L, Tattevin P, Bru JP, Duval X, Hoen B, et al. Oral switch versus standard intravenous antibiotic therapy in left-sided endocarditis due to susceptible staphylococci, streptococci or enterococci (RODEO): a protocol for two open-label randomised controlled trials. BMJ Open. 2020;10(7):e033540.
7. Burdet C, Saidani N, Dupieux C, Lemaignen A, Canoui E, Surgers L, et al. Cloxacillin versus cefazolin for meticillin-susceptible Staphylococcus aureus bacteraemia (CloCeBa): a prospective, open-label, multicentre, non-inferiority, randomised clinical trial. Lancet. 2025;406(10517):2349-59.
8. Azoulay E, Russell L, Van de Louw A, Metaxa V, Bauer P, Povoa P, et al. Diagnosis of severe respiratory infections in immunocompromised patients. Intensive Care Med. 2020;46(2):298-314.
","author_name":"Helse Bergen"}